Clinical Trials Logo

Clinical Trial Summary

The objective of this study was to prospectively compare effectiveness of Ankaferd Blood Stopper (ABS) with dry sponges in cessation of bleeding in adult trauma cases with external bleeding due to extremity lacerations.

Methods: The study was conducted on patients with bleeding associated with extremity lacerations. All consecutive patients presented to the emergency department of the high-volume training hospital in Istanbul were recruited within the study period


Clinical Trial Description

This study was planned as a prospective randomized study. After local ethics committee approval, all consecutive patients admitted to the Emergency Department of the Haydarpasa Numune Training & Research Hospital due to extremity lacerations between October 1st and October 11th 2018 were recruited. The longest duration for wound healing, infection follow-up, and suture removal was 12 days. Therefore, the study was completed in a total of 23 days after suture removal of the last case.

ABS which was approved in 2017 by the Ministry of Health, is being used routinely in the management of the patients with traumatic bleeding in the emergency department of the hospital. Nurses working in treatment areas of the department were trained for this prospective study. They were trained to apply compression of approximately 3-kg weight after irrigation with saline in patients with active bleeding who met inclusion criteria. Bleeding was controlled in every minute and data were collected. Traditional methods such as primary suturing were performed in patients whose bleeding did not stop within 10 minutes. Patients whose bleeding was stopped were monitored for half an hour for bleeding recurrence.

The patients were divided into two groups; ones treated by ABS soaked wet compresses (group I) and ones treated by dry sponge compresses (group II). Demographic data, systemic disease history, drugs used, injury mechanism, habits etc. of the patients enrolled in the study were recorded into data collection form.

Forty commercially prepared ABS-soaked wet sterile sponges and 40 dry sponges of 2.5x7 cm were randomly numbered and placed in a box in the study area. Random numbers table was used to generate the sequence of enumeration of the sponges. Any given patient was treated with the next sponge with the smallest number in the box and data sheets contained the number of the sponge with which the patient's bleeding was intervened. Therefore, allocation concealment was accomplished for the study purposes.

In both groups, lacerations that did not stop bleeding within 10 minutes and lacerations with recurred bleeding within the half-hour follow-up period were repaired by the primary suturing. Lacerations were sutured at the end of follow-up period in other patients. Daily dressing was recommended to the patients at discharge, and they were invited for a follow-up visit 3 days later. They were followed-up for wound infection. Suture removal date was recorded in data collection form.

Statistical analysis was conducted by using the MedCalc Statistical Software version 12.7.7 (MedCalc Software bvba, Ostend, Belgium; http://www.medcalc.org; 2013). Descriptive statistics were used to define continuous variables in this study (mean, standard deviation, range, and median). Mann Whitney U test was used to compare two independent and abnormally distributed groups. Chi-square test was performed to compare categorical variables, or Fisher's Exact test was performed where appropriate or required. Statistical significance level was determined as p<0.05. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03871452
Study type Interventional
Source Haydarpasa Numune Training and Research Hospital
Contact
Status Completed
Phase N/A
Start date October 1, 2018
Completion date October 23, 2018

See also
  Status Clinical Trial Phase
Completed NCT03834727 - Characterizing the Impact and Treatment of Reproductive Tract Bleeding on Women and Post-menarchal Girls With Bleeding Disorders
Recruiting NCT04398628 - ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Completed NCT00772434 - Assessment of Bleeding Symptoms in Normal Individuals Using a Comprehensive History Phenotyping Instrument N/A
Recruiting NCT03095625 - Role of Thromboelastography in Septic Shock N/A
Recruiting NCT04600609 - Examining the Experiences of Children With Blood Disorders
Completed NCT02979158 - Preoperative Dual Antiplatelet Therapy: Platelet Function and Influence of Cardiopulmonary Bypass N/A
Active, not recruiting NCT04912336 - Extracorporeal Life Support and Modification of Hemostasis
Terminated NCT05790109 - Operator and Patient Acceptance of Radiofrequency Cautery of the Biopsy Track During Percutaneous Liver, Kidney or Spleen Biopsy Procedures. N/A
Not yet recruiting NCT05916469 - Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
Recruiting NCT06250595 - European Rare Blood Disorders Platform (ENROL)
Completed NCT03355742 - XIENCE 28 Global Study N/A
Completed NCT03815175 - XIENCE 28 USA Study N/A
Completed NCT03444324 - Adjusted Fibrinogen Replacement Strategy Phase 3
Completed NCT02864875 - Early Administration of Fibrinogen in Polytraumatized Patients With Hypofibrinogenemia: a Randomized Feasibility Trial Phase 4
Completed NCT04201860 - Blood Gas and Bleeding Disorders in Healthy Volunteers Exposed to Nitroglycerin and Nitrogen Compounds
Recruiting NCT04645199 - National Longitudinal Cohort of Hematological Diseases
Completed NCT05214300 - Screening for Bleeding Disorders in Children
Not yet recruiting NCT06118372 - Recombinant vWF Concentrate and ECMO Phase 1
Active, not recruiting NCT04188171 - Sclerotherapy With Polidocanol Foam In The Treatment Of Hemorrhoidal Disease In Patients With Bleeding Disorders Phase 2/Phase 3
Completed NCT06039904 - Protection of Knee Joints in Bleeding Disorder Patients N/A